[Antibodies to citrullinated peptides in rheumathoid arthritis].
Rheumatoid arthritis is a systemic autoimmune disease characterized by chronic inflammation of the synovial joints leading to progressive joint destruction. The serum of these patients contains a large repertoire of autoantibodies, mainly rheumatoid factor, which is part of the ACR classification criteria in spite of having only moderate specificity. Antibodies directed to citrullinated proteins provide clinicians with a valuable tool for early diagnosis. It has been shown that these antibodies can be detected years before presentation of the first symptom and are very useful for diagnosis and prognosis, due to good sensitivity and specificity and prediction of development of erosive disease. The immune response against citrullinated antigens is characteristic of an immuno-genetic subtype of disease, in which the combined role of genes, environmental factors and autoimmunity has become the prime suspected for disease pathogenesis. A model is proposed of how these antibodies are produced and lead to chronic synovial inflammation.
Balsa
Alejandro
A
Servicio de Reumatología, Hospital Universitario La Paz, Madrid, España. abalsa.hulp@salud.madrid.org
Pascual-Salcedo
Dora
D
Martín
Javier
J
D000906:Antibodies / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000209:etiology*; D006801:Humans; D010456:Peptides, Cyclic / Q000276:immunology*; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity
D000906:Antibodies; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide